Now accepting Telehealth appointments. Schedule a virtual visit.

Peptide Therapy At Modern Wellness Clinic


Med Spa located in Las Vegas, NV

Peptides are small chains of amino acids that have been a primary focus for researcher, clinician, and scientists over the last decade because of their ability to stimulate and communicate with hormones. When supplemented under the guidance of a certified professional, peptide therapy can stimulate secretion of hormones that regulate vital body processes such as metabolism, sleep, repair, recovery, energy, fat-burning, and more.

Peptide Therapy Products at Modern Wellness Clinic

5-Amino-1MQ has been shown in research to address age-related decline in fat-burning capacity. Adequate dosing and pairing 5-Amino-1MQ with a complementary treatment plan typically restores the body’s natural ability to burn excess fat.
5-Amino-1MQ naturally reduces the concentrations of nicotinamide N-methyltransferase (NNMT), facilitating weight  loss and better health in older adults.

About 5-Amino-1MQ
5-Amino-1MQ is a small, selective, membrane permeable molecule that is an inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that plays a role in cellular metabolism and energy homeostasis. NNMT has been found to be upregulated in white adipose tissue of mice compared to other tissues, thus, NNMT is an ideal target for an 
anti-obesity medication. 5-amino-1MQ is a derivative of methyl quinolinium (MQ) which has exhibited a high efficacy in NNMT inhibition, cell viability, and membrane permeability. It does not have any effect on the activity of any other enzymes in the relevant metabolic cycles, therefore reducing the risks of potential side effects. This NNMT inhibitor could be used to prevent adipogenesis and type II diabetes and reverse diet-induced obesity as a result 
of increased intracellular NAD+ and SAM.
About ARA-290 (Cibinetide Acetate)
ARA-290 is a peptide currently being researched for its safety
and efficacy for the treatment of neuropathic pain in patients
with sarcoidosis, as well as its potential for disease modification
and long-term support functional improvement in this condition
About BPC-157
Pentadecapeptide BPC 157, composed of 15 amino acids, is a 
partial sequence of body protection compound (BPC) that 
is discovered in and isolated from human gastric juice. 
Experimentally, it has been demonstrated to accelerate 
the healing of many different wounds, including tendonto-bone healing and superior healing of damaged 
CJC 1295 acts on the pituitary gland to maximize levels of growth 
hormone in the body. Increased volume of human growth hormone
(hGH) production in the pituitary gland supports increased
production of insulin-like growth factor (IGF-1) by the liver and
results in multiple health benefits.

About CJC 1295
CJC 1295 is a tetrasubstituted 29-amino acid peptide hormone,
primarily functioning as a growth hormone releasing hormone (GHRH) 
analog. CJC 1295 outperforms the older and outdated GHRH, Sermorelin. 
The half-life of Sermorelin ranges from 8-12 minutes, whereas the half-life of 
CJC 1295 extends to 30 minutes. Sermorelin’s efficacy decreases with time 
and the body produces antibodies to Sermorelin, bioconjugate with serum 
albumin, thus increasing its half-life and potential therapeutic window. It 
accomplishes this by using protecting groups around the amino acids of 
GHRH typically susceptible to enzymatic degradation, thus increasing the 
half-life. Consequently CJC 1295 without DAC is designed to provide a GHRHlike stimulation around the clock with increased amplitude and longer 
stimulation, (28 minutes instead of 8-12 of sermorelin), maintaining the natural 
pulsatile stimulation of the pituitary without decreasing secretion as observed 
in CJC with DAC.
Dihexa is a known as a cognitive enhancer. It is a peptide 
designed to support certain cognitive functions, help improve 
mental stamina, and short-term and long-term memory 
capacity. In some cases, Dihexa has been shown to support 
treatment for dementia, Alzheimer’s and other conditions 
or traumas that impact the brain, including helping repair 
brain damage.

About Dihexa
Dihexa is a peptide variant derived from angiotensin IV 
which has been found to potentially improve cognitive 
function in animal models of diseases such as Alzheimer’s. Angiotensin IV is 
a derivative of the potent vasoconstrictor angiotensin II and has been shown 
to enhance acquisition, consolidation, and recall of learning and memory 
in animal models when administered centrally or peripherally. In an assay 
of neurotrophic activity, Dihexa was found to be seven orders of magnitude 
more potent than BDNF. It could possibly help in the repair of the brain and 
nerves in neurological disease.
Ipamorelin is among the widely sought-after peptide therapies. It 
supports the release of growth hormone (GH) by mimicking ghrelin. 
By acting on the pituitary gland, ipamorelin elevates a “pulse” 
duration of GH—delivering a longer duration after administration 
compared to other growth hormone releasing peptides. Ipamorelin 
stimulates production of insulin-like growth factor (IGF-1) as well, 
further enhancing anti-aging, athletic, and total health benefits.
In conjunction with the right treatment plan, ipamorelin has been shown to 
decrease body fat, improve weight loss, muscle recovery, promote better 
sleep, and enhance immune function, cellular repair and collagen production.

About Ipamorelin
Ipamorelin is a selective GH-Secretagogue and ghrelin receptor agonist. 
The potency of ghrelin stimulation can be compared to GHRP6 with less 
appetite stimulation properties. However, unlike other GH-Secretagogues this 
pentapeptide doesn’t release the same volumes of cortisol, acetylcholine, 
prolactin, and aldosterone. It is for this reason Ipamorelin has been considered 
the first selective GH Secretagogue.
LL-37 is commonly called, “the little peptide with big uses.” It 
has been shown to have antimicrobial effects against infection, 
including MRSA and HIV. It is also useful for chronic wound healing 
and inflammatory conditions of the GI tract. There has been 
evidence that LL-37 is helpful in the treatment of certain cancers, 
but that list is heavily limited to colon cancer, gastric cancer, 
hematologic malignancy, and oral squamous cell carcinoma. LL37 is reported to induce tumorigenic effects in cancers.

About LL-37
Cationic host defense peptides such as LL-37 are key components of 
innate defenses against infection, with both microbicidal and host defense 
modulatory functions. In addition to their well-described bactericidal 
potential, CHDP have more recently been shown to have antiviral properties. 
LL-37 has been shown to be highly effective in preventing viral attachment 
to cells. Used in several virus studies and has been anecdotally reported to 
work well with respiratory tract viruses. Caution in patients with known autoimmune disorders. Worsening auto-immune symptoms have been reported 
with LL-37
Shown in research to be one of the most potent and highly 
effective selective androgen receptor modulators (SARM), 
LGD-4033, creates anabolic activity in the bones and muscles. 
This function makes LGD-4033 an effective treatment option 
to support strength, increased lean muscle mass, exercise 
recovery, and reduced body fat.

About LGD-4033
LGD-4033 has a safe, favorable pharmacokinetic profile, and 
increases lean body mass without change in prostatespecific antigen. In research studies, hemoglobin, prostatespecific antigen, aspartate aminotransferase, alanine aminotransferase, 
or QT intervals did not change significantly at any dose. LGD-4033 had a 
long elimination half-life and dose-proportional accumulation upon multiple 
dosing. LGD-4033 administration is typically associated with dose-dependent 
suppression of total testosterone, sex hormone–binding globulin, high density 
lipoprotein cholesterol, and triglyceride levels. Follicle-stimulating hormone and 
free testosterone showed significant suppression at 1.0-mg dose only
Melanotan is a peptide that increases the amount of melanin in the 
skin to support protection against UV rays and induce skin tanning. 
Other benefits associated with Melanotan II include increased sexual 
desire, appetite control, neuroprotection, cardiovascular health 
support, and treatment for erythropoietic protoporphyria. Patients 
with a history of melanoma or at high-risk of melanoma are not 
good candidates.

About Melanotan II
Melanotan II is an analogue of the peptide hormone alpha-melanocytestimulating hormone (a-MSH) that induces skin tanning. It was originally 
developed by the University of Arizona in the 1980s to treat people who were 
intolerant to the sunlight. Melanotan II plays a role in melanogenesis in 
protecting the skin from UV light. There are five melanocortin receptors each 
with a different function. MT 2 binds primarily to MC-4R and MC-1R, and weakly 
to MC-3R.
MK-677 is known to improve growth hormone levels and impact 
the area of the brain that controls appetite, mood, memory, 
and cognition. The benefits of MK-677 in conjunction with 
complementary therapies are shown to support musclebuilding, reduce muscle wasting, improve bone density, 
promote better sleep, and support anti-aging effects related 
to growth hormone deficiencies.
About MK-677
MK-677 is a long active orally bioactive agonist of the GHSR1a. As such, it binds to the same receptor that GHRP2, GHRP6, and Ipamorelin 
also stimulate. Also called Ibutamoren, it has shown to cause a predictable 
rise in IGF-1 but unlike other GH secretagogues, it doesn’t help to decrease 
adipose tissue. It has been shown to increase lean muscle mass and might 
be a good candidate for sarcopenic patients with low bone mineral density. 
To reduce the negative effect of somatostatin, MK-677 is best taken on an 
empty stomach with no insulin in the system
PT-141, also known as Bremelanotide, is an innovative peptide 
hormone treatment shown to be effective for improving sexual 
function in men and women. PT-141 supports treatment of erectile 
dysfunction and increased libido in men and improves female 
sexual arousal disorder in women. PT-141 works directly through the 
nervous system to increase arousal, desire, and satisfaction with 
sex. PT-141 peptide induces desire and motivation for sex, increases 
blood flow to the penis or vagina and clitoris. 

About PT-141 (Bremelanotide)
Bremelanotide (PT-141) is a derivative of the peptide hormone, Melanotan II. In 
initial testing, Melanotan II induced darkening of skin pigment, but additionally 
caused sexual arousal and spontaneous erections as unexpected side 
effects in nine out of the ten original male volunteer test subjects. Further 
testing in animals showed Bremelanotide to induce lordosis (a sexual mating 
behavior) and subsequently tested for its effect in humans. Although, most 
of the research has been targeted to women with female sexual dysfunction 
and it is effective medication in treating sexual dysfunction in both men 
(erectile dysfunction or impotence) and women (sexual arousal disorder)
Selank is classified as a synthetic peptide because it is made by 
combining the sequence of the peptide tuftsin with another peptide 
to improve molecular stability. In research, Selank has been shown to 
reduce anxiety, improve learning a